ARQ-154 Foam

· Arcutis Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ARQ-154 Foam, covering 2022-09-30 to 2024-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis [Phase 2]